Systemic Inflammation Differences in Brain-vs. Circulatory-Dead Donors: Impact on Lung Transplant Recipients

Transpl Int. 2024 Jun 3:37:12512. doi: 10.3389/ti.2024.12512. eCollection 2024.

Abstract

Brain death triggers a systemic inflammatory response. Whether systemic inflammation is different in lung donors after brain- (DBD) or circulatory-death (DCD) is unknown, but this may potentially increase the incidence of primary graft dysfunction (PGD) after lung transplantation. We compared the plasma levels of interleukin (IL)-6, IL-8, IL-10 and TNF-α in BDB and DCD and their respective recipients, as well as their relationship with PGD and mortality after LT. A prospective, observational, multicenter, comparative, cohort-nested study that included 40 DBD and 40 DCD lung donors matched and their respective recipients. Relevant clinical information and blood samples were collected before/during lung retrieval in donors and before/during/after (24, 48 and 72 h) LT in recipients. Incidence of PGD and short-term mortality after LT was recorded. Plasma levels of all determined cytokines were numerically higher in DBD than in DCD donors and reached statistical significance for IL-6, IL-10 and IL-8. In recipients with PGD the donor's plasma levels of TNF-α were higher. The post-operative mortality rate was very low and similar in both groups. DBD is associated with higher systemic inflammation than DCD donors, and higher TNF-α plasma levels in donors are associated with a higher incidence of PGD.

Keywords: brain-death donation; circulatory-death donation; cytokine storm; interleukin; lung transplantation.

Publication types

  • Multicenter Study
  • Observational Study
  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Brain Death*
  • Cytokines / blood
  • Female
  • Humans
  • Inflammation* / blood
  • Interleukin-10 / blood
  • Interleukin-6 / blood
  • Interleukin-8 / blood
  • Lung Transplantation* / adverse effects
  • Male
  • Middle Aged
  • Primary Graft Dysfunction* / blood
  • Primary Graft Dysfunction* / etiology
  • Prospective Studies
  • Tissue Donors*
  • Transplant Recipients
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Interleukin-6
  • Interleukin-8
  • Cytokines

Grants and funding

The author(s) declare(s) financial support was received for the research, authorship, publication of this article. The author(s) declare(s) that this work was performed with the financial support of Fundación Invest. Médica Mutua Madrileña Ref: AP167192017.